Report cover image

Europe Stem Cell Market Forecast 2022-2030

Publisher Inkwood Research
Published Sep 19, 2022
Length 140 Pages
SKU # INKR17391817

Description

Europe Stem Cell Market Forecast 2022-2030KEY FINDINGS

The Europe stem cell market is set to grow with a CAGR of 8.60% over the forecast period of 2022 to 2030. The region’s market growth is strengthened by the rise in product releases, the increasing incidence of target conditions, the surge in awareness about stem cell-based therapies for different hair and skin disorders, and strategic initiatives like collaborations and agreements.

MARKET INSIGHTS

The Europe stem cell market growth study comprises the evaluation of the United Kingdom, Poland, Italy, France, Belgium, Germany, and Rest of Europe. As per the World Population Ageing report published in 2019, France had 13.28 million people aged 65 years and over. While this number is estimated to reach 16.09 million by 2030, the stem cell market in France is projected to witness substantial growth over the upcoming years, owing to the surge in the geriatric population.

On the other hand, given the rising number of chronic diseases in Italy, investments in research and development for developing effective treatments and clinical trials for stem cell therapy are anticipated to increase significantly. As per the estimations issued by AIRTUM 2020, around 377,000 new cases of malignant tumors were diagnosed in Italy, including 182,000 and 195,000 in women and men, respectively. Furthermore, the COVID-19 pandemic is one of the key factors driving the market demand in Italy. As a result, these factors are set to facilitate the Europe stem cell market growth during the forecast period.

COMPETITIVE INSIGHTS

Some of the main firms operating in the market are Qiagen, Smith+Nephew PLC, Merck KGaA (Sigma Aldrich), etc.

Our report offerings include:

• Explore key findings of the overall market

• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions

• Market Segmentation caters to a thorough assessment of key segments with their market estimations

• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Table of Contents

140 Pages
1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Key Drivers
3.1.1. Surging Demand For Stem Cells In Regenerative Medicine
3.1.2. Growing R&D Investments In Stem Cell Therapies & Research
3.1.3. Rising Awareness About Umbilical Cord Stem Cells
3.1.4. Reduced Risk Of Tissue Rejection In Transplants
3.2. Key Restraints
3.2.1. Absence Of A Well-defined Regulatory Framework For Stem Cell Therapy
3.2.2. High Costs Associated With Stem Cell Procedures
3.2.3. Ethical Issues And Social Complexities
3.2.4. Less Responsiveness In Developed Economies
4. Key Analytics
4.1. Impact Of Covid-19 On Stem Cell Market
4.2. Key Market Trends
4.3. Porter’s Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Vendor Landscape
4.6. Value Chain Analysis
4.7. Key Buying Criteria
4.7.1. Price
4.7.2. Efficacy
4.7.3. Application And Effectiveness
4.7.4. Accuracy
4.8. Regulatory Framework
5. Market By Therapeutic Application
5.1. Orthopedic Treatments
5.2. Injuries & Wounds
5.3. Oncology Disorders
5.4. Cardiovascular Disorders
5.5. Neurological Disorders
5.6. Diabetes
5.7. Other Therapeutic Applications
6. Market By Product
6.1. Adult Stem Cell
6.1.1. Hematopoietic Stem Cell
6.1.2. Neural Stem Cell
6.1.3. Umbilical Cord Stem Cell
6.1.4. Mesenchymal Stem Cell
6.1.5. Dental Stem Cell
6.2. Human Embryonic Stem Cell
6.3. Pluripotent
6.4. Mouse/Rat Neural
7. Market By Technology
7.1. Cell Acquisition
7.1.1. Bone Marrow Harvest
7.1.2. Umbilical Cord
7.1.3. Apheresis
7.2. Cell Production
7.2.1. Therapeutic Cloning
7.2.2. In Vitro Fertilization (Ivf)
7.2.3. Cell Culture
7.2.4. Isolation
7.3. Cryopreservation
7.4. Expansion & Sub-culture
8. Market By Application
8.1. Regenerative Medicine
8.2. Drug Discovery And Development
9. Market By Treatment Type
9.1. Allogeneic Stem Cell Therapy
9.2. Autologic Stem Cell Therapy
9.3. Syngeneic Stem Cell Therapy
10. Geographical Analysis
10.1. Europe
10.1.1. Market Size & Estimates
10.1.2. Key Growth Enablers
10.1.3. Key Challenges
10.1.4. Key Players
10.1.5. Country Analysis
10.1.5.1. United Kingdom
10.1.5.2. Germany
10.1.5.3. France
10.1.5.4. Italy
10.1.5.5. Belgium
10.1.5.6. Poland
10.1.5.7. Rest Of Europe
11. Competitive Landscape
11.1. Key Strategic Developments
11.1.1. Acquisitions
11.1.2. Partnerships
11.2. Company Profiles
11.2.1. Allcells Llc
11.2.2. Becton, Dickinson And Company (Bd)
11.2.3. Corning Inc
11.2.4. Ge Healthcare
11.2.5. International Stem Cell Corporation
11.2.6. Lorem Cytori Inc
11.2.7. Merck Kgaa (Sigma Aldrich)
11.2.8. Miltenyi Biotec
11.2.9. Pluri Inc
11.2.10. Qiagen
11.2.11. Smith+Nephew Plc
11.2.12. Stemcell Technologies Inc
11.2.13. Stryker Corporation
11.2.14. Takara Holdings Inc
11.2.15. Thermo Fisher Scientific Inc

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us